Clover Health Investments, Corp. CLOV
4.49
(0.02)
(0.44%)
as of 25 Sep
- Market cap
- $2.5B
- P/E
- 0.0×
Follow CLOV
Growth Flags
show if company had growth for consecutive years
| Dec '17 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | 0.00 | 2.21 | 1.04 | 0.41 | 0.37 | 1.13 | 0.63 |
P/FCF ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 46.37 | 0.00 |
P/Operating CF |
— | (24.24) | (24.83) | (19.16) | (2.16) | (1.79) | (17.98) | (17.65) |
P/B ratio |
— | 121,753.54 | 0.00 | 2.85 | 1.27 | 1.62 | 4.52 | 3.90 |
Price to Tangible BV |
— | 121,753.54 | 0.00 | 2.87 | 1.34 | 1.63 | 4.56 | 3.94 |
EV/Sales |
— | 0.00 | 2.26 | 0.65 | 0.11 | 0.18 | 0.97 | 0.57 |
EV/EBITDA |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | 0.00 | (12.81) | (3.41) | (0.60) | (1.60) | 38.06 | (16.24) |
EV/FCF |
— | 0.00 | (12.73) | (3.40) | (0.59) | (1.59) | 39.84 | (15.76) |
Quick Ratio |
— | 0.00 | 0.89 | 1.82 | 0.99 | 1.15 | 1.28 | 1.03 |
Current Ratio |
— | 0.00 | 1.16 | 2.02 | 1.45 | 1.64 | 1.61 | 1.47 |
Net Debt/EBITDA |
— | 0.00 | (0.43) | 0.96 | 1.15 | 1.14 | 4.72 | 1.40 |
Debt/Assets |
0.00% | 0.00% | 47.60% | 2.10% | 0.69% | 0.24% | 0.00% | 0.00% |
Debt/Equity |
— | 0.00 | (0.21) | 0.04 | 0.02 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
— | 9,217.67 | 5.03 | 2.42 | 1.25 | 1.83 | 2.38 | 3.43 |
Operating CF/Net income |
— | 0.44 | 0.87 | 0.48 | 0.60 | 0.68 | (0.81) | 0.78 |
Capex/Depreciation |
— | 0.00 | (0.03) | (0.05) | 15.62 | 0.39 | 1.30 | 13.01 |
Interest Coverage |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | 117.88% | 44.48% | 1,591.19% | (75.78%) | (66.34%) | (13.71%) | (26.33%) | |
| — | (725,298.11%) | (102.03%) | (96.51%) | (38.60%) | (30.94%) | (7.47%) | (15.25%) | |
ROIC |
— | 0.00% | 0.00% | 0.00% | (646.22%) | (249.05%) | (23.91%) | (28.37%) |
Return on Tangible Assets |
— | 308,251.69% | (493.60%) | (153.78%) | (170.43%) | (124.09%) | (31.88%) | (81.15%) |
Average Days of Receivables |
— | 0.00 | 27.18 | 15.45 | 31.36 | 18.58 | 13.72 | 17.99 |
Research and Development Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
— | 40.52% | 28.55% | 30.28% | 43.99% | 34.93% | 29.82% | 22.85% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.02 | 0.00 | 0.02 | 0.01 | 0.01 | 0.01 |
Share Based Compensation of Revenue |
— | 0.71% | 1.05% | 11.12% | 14.98% | 11.18% | 8.34% | 5.39% |
Graham Net Nets |
— | 0.00 | (0.46) | 0.22 | 0.38 | 0.31 | 0.07 | 0.06 |
Graham Number |
— | 0.00 | 15.47 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | 0.00% | (9.17%) | (38.44%) | (75.79%) | (46.88%) | (2.86%) | (7.34%) |
Free Cash Flow Yield |
— | 0.00% | (8.01%) | (18.43%) | (46.06%) | (31.38%) | 2.16% | (5.73%) |
Revenue per Share |
— | 5.26 | 7.59 | 3.56 | 2.30 | 2.61 | 2.80 | 3.76 |
Operating CF per Share |
— | (1.82) | (1.34) | (0.68) | (0.43) | (0.30) | 0.07 | (0.13) |
Capex per Share |
— | 0.00 | (0.01) | 0.00 | (0.01) | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
— | (1.82) | (1.34) | (0.69) | (0.44) | (0.30) | 0.07 | (0.13) |
Cash per Share |
— | 0.00 | 1.09 | 1.49 | 0.70 | 0.49 | 0.45 | 0.23 |
Shareholders Equity per Share |
— | 0.00 | (6.91) | 1.31 | 0.75 | 0.59 | 0.70 | 0.60 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 0.00 | (6.91) | 1.31 | 0.75 | 0.59 | 0.70 | 0.60 |
Free Cash Flow |
— | (159.90) | (119.19) | (283.05) | (208.39) | (145.25) | 33.29 | (68.98) |
Working Capital |
— | (0.12) | 25.55 | 379.92 | 193.49 | 166.86 | 129.61 | 99.03 |
Capital Expenditures |
— | (0.02) | (0.69) | (0.72) | (4.47) | (0.58) | (1.56) | (2.04) |
Net Current Asset Value |
— | (0.12) | (690.66) | 341.06 | 173.26 | 143.69 | 103.53 | 75.55 |
EV/EBIT |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
— | (78.69%) | (20.27%) | (39.93%) | (30.97%) | (16.93%) | (3.14%) | (4.45%) |
Price to Operating Income |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||
Depreciation/Fixed assets |
— | 0.00 | 10.34 | 6.63 | (0.05) | (0.30) | (0.22) | (0.02) |
Cash ROIC |
— | 908,380.68% | 30.98% | (24.23%) | (30.07%) | (28.58%) | 5.25% | (17.09%) |
Accounts Receivable Turnover |
— | 0.00 | 11.97 | 26.18 | 14.01 | 15.92 | 23.70 | 26.29 |
Accounts Payable Turnover |
— | 0.00 | 20.07 | 52.76 | 32.79 | 28.86 | 28.05 | 44.32 |
Inventory Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
— | 0.00 | 18.97 | 6.62 | 11.93 | 13.51 | 12.54 | 8.43 |
Days of Inventory on Hand |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | — | 56.22 | 56.22 | 78.26 | 79.18 | 57.85 | 73.20 |
Average Payables |
— | — | 29.40 | 29.40 | 30.29 | 34.81 | 35.87 | 35.39 |
Average Assets |
— | 0.05 | 133.68 | 609.03 | 879.71 | 689.65 | 575.71 | 560.88 |
Average Common Equity |
— | (308.56) | (306.61) | (36.94) | 448.10 | 321.64 | 313.77 | 324.92 |
Columns are period end dates